Gene · 5424
Papers4,215
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,215
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic Identification of Molecular Signatures Dictating Therapeutic Effects of Clinically First-Line Chemotherapy Regimens for Human Gastric Cancer Patients Based on Organoid Model. | MedComm (2020) | 2026 | 41782964 | PubTator, text mining | PubMed |
| ctDNA guided management of POLE mutant GI malignancies promotes exceptional responses and prolonged survival to immunotherapy. | Front Immunol | 2026 | 41782871 | PubTator, text mining | PubMed |
| Clinicopathologic, molecular and tumor immune microenvironment features of mismatch repair-deficient glioblastomas in Lynch syndrome: a multicenter study of 29 cases with therapeutic implications. | Acta Neuropathol Commun | 2026 | 41782063 | PubTator, text mining | PubMed |
| Genomic Landscape of Poorly Differentiated Gastric Carcinoma: An AACR GENIE® Project. | Life (Basel) | 2026 | 41752847 | PubTator, text mining | PubMed |
| Molecular Basis of Adenomatous Gastrointestinal Polyposis Syndromes: Role of Pathogenic and Benign Variants in Disease Onset. | Biomedicines | 2026 | 41751327 | PubTator, text mining | PubMed |
| Genotype-phenotype heterogeneity among patients with lipodystrophy harboring rare POLD1 variants. | J Clin Endocrinol Metab | 2026 | 41742372 | PubTator, text mining | PubMed |
| Deficient mismatch repair/microsatellite instability-high colorectal cancer: current treatment paradigms, limitations and future perspectives. | BMJ Oncol | 2026 | 41710674 | PubTator, text mining | PubMed |
| Multiomics assessment of lung adenocarcinoma subtypes defined through tumor purity-adjusted DNA methylation. | Genome Med | 2026 | 41691315 | PubTator, text mining | PubMed |
| Hereditary Endometrial Cancer: Lynch Syndrome, Mismatch Repair Deficiency, and Emerging Genetic Predispositions-A Comprehensive Review with Clinical and Laboratory Guidelines. | Int J Mol Sci | 2026 | 41683729 | PubTator, text mining | PubMed |
| Simultaneous Study of Circular RNAs and Messenger RNAs in Colorectal Cancer: The Unbalanced Fate of a Couple? | Cancers (Basel) | 2026 | 41681969 | PubTator, text mining | PubMed |
| Differential functions of human DNA polymerase delta with p12 variants during DNA replication and DNA damage response. | Mol Biol Cell | 2026 | 41671062 | PubTator, text mining | PubMed |
| The molecular profile of ovarian struma ovarii. | Hum Pathol | 2026 | 41655861 | PubTator, text mining | PubMed |
| A non-catalytic role for RFC in PCNA-mediated processive DNA synthesis. | Cell | 2026 | 41610851 | PubTator, text mining | PubMed |
| Tislelizumab plus bevacizumab and XELOX as first-line treatment of MSS/pMMR RAS-mutant metastatic colorectal cancer (TACTIC CRC-02): a phase II study. | ESMO Open | 2026 | 41610691 | PubTator, text mining | PubMed |
| Molecular Classification and Clinical Outcomes in Endometrial Cancer: Real-World Evidence from a Tertiary Care Center. | Cancers (Basel) | 2026 | 41595105 | PubTator, text mining | PubMed |
| Evolution of AR and Non-AR Alterations in ctDNA of Patients with Metastatic Prostate Cancer Treated in the Phase III Alliance A031201 Trial. | Clin Cancer Res | 2026 | 41587107 | PubTator, text mining | PubMed |
| Correction for Tian et al., DNA polymerase delta governs parental histone transfer to DNA replication lagging strand. | Proc Natl Acad Sci U S A | 2026 | 41557817 | PubTator, text mining | PubMed |
| Integrating evidence from protein domains to identify cancer driver mutations. | Protein Sci | 2026 | 41556616 | PubTator, text mining | PubMed |
| Commonalities in gene expression and methylation changes across two rat models of acquired epilepsy. | Sci Rep | 2026 | 41530481 | PubTator, text mining | PubMed |
| [Surgical Management of Hereditary Colorectal Cancer Syndromes]. | Zentralbl Chir | 2026 | 41213597 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5424/papers?page=3